382 related articles for article (PubMed ID: 28466551)
1. Functionality testing of stem cell grafts to predict infectious complications after allogeneic hematopoietic stem cell transplantation.
Nilsson J; Granrot I; Mattsson J; Omazic B; Uhlin M; Thunberg S
Vox Sang; 2017 Jul; 112(5):459-468. PubMed ID: 28466551
[TBL] [Abstract][Full Text] [Related]
2. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ma CK; Blyth E; Clancy L; Simms R; Burgess J; Brown R; Deo S; Micklethwaite KP; Gottlieb DJ
Cytotherapy; 2015 Oct; 17(10):1406-20. PubMed ID: 26349000
[TBL] [Abstract][Full Text] [Related]
3. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis.
Düver F; Weißbrich B; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
PLoS One; 2020; 15(2):e0228451. PubMed ID: 32017805
[TBL] [Abstract][Full Text] [Related]
4. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.
Sahin U; Toprak SK; Atilla PA; Atilla E; Demirer T
J Infect Chemother; 2016 Aug; 22(8):505-14. PubMed ID: 27344206
[TBL] [Abstract][Full Text] [Related]
5. Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation.
Kaeuferle T; Krauss R; Blaeschke F; Willier S; Feuchtinger T
J Hematol Oncol; 2019 Feb; 12(1):13. PubMed ID: 30728058
[TBL] [Abstract][Full Text] [Related]
6. Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant.
Sili U; Leen AM; Vera JF; Gee AP; Huls H; Heslop HE; Bollard CM; Rooney CM
Cytotherapy; 2012 Jan; 14(1):7-11. PubMed ID: 22172091
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of viral infections among children undergoing hematopoietic stem cell transplant: Α prospective single-center study.
Tsoumakas K; Giamaiou K; Goussetis E; Graphakos S; Kossyvakis A; Horefti E; Mentis A; Elefsiniotis I; Pavlopoulou ID
Transpl Infect Dis; 2019 Aug; 21(4):e13095. PubMed ID: 30993823
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous Quantification of the 8 Human Herpesviruses in Allogeneic Hematopoietic Stem Cell Transplantation.
Gomes de Oliveira PG; Ueda MY; Real JM; de Sá Moreira E; Rodrigues de Oliveira JS; Gonçalves MV; Ginani VC; de Oliveira Felix OM; Seber A; Novis Y; Rocha V; Granato CF; Arrais-Rodrigues C
Transplantation; 2016 Jun; 100(6):1363-70. PubMed ID: 26555946
[TBL] [Abstract][Full Text] [Related]
9. Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults.
Galletta TJ; Lane A; Lutzko C; Leemhuis T; Cancelas JA; Khoury R; Wang YM; Hanley PJ; Keller MD; Bollard CM; Davies SM; Grimley MS; Rubinstein JD
Transplant Cell Ther; 2023 May; 29(5):305-310. PubMed ID: 36736781
[TBL] [Abstract][Full Text] [Related]
10. The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.
Olkinuora H; von Willebrand E; Kantele JM; Vainio O; Talvensaari K; Saarinen-Pihkala U; Siitonen S; Vettenranta K
Scand J Immunol; 2011 Jun; 73(6):586-93. PubMed ID: 21323694
[TBL] [Abstract][Full Text] [Related]
11. Lymphoproliferative response to herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, human herpes virus 6, 7, and 8 antigen stimulation in pediatric allogeneic stem cell transplant recipients.
Cheng FW; Chan PK; Lee V; Leung WK; Shing MK; Li CK; Leung TF
Pediatr Transplant; 2010 Sep; 14(6):761-9. PubMed ID: 20534025
[TBL] [Abstract][Full Text] [Related]
12. Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation.
Ip W; Silva JMF; Gaspar H; Mitra A; Patel S; Rao K; Chiesa R; Amrolia P; Gilmour K; Ahsan G; Slatter M; Gennery AR; Wynn RF; Veys P; Qasim W
Cytotherapy; 2018 Jun; 20(6):830-838. PubMed ID: 29753677
[TBL] [Abstract][Full Text] [Related]
13. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
[TBL] [Abstract][Full Text] [Related]
14. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
[TBL] [Abstract][Full Text] [Related]
15. Cord blood graft composition impacts the clinical outcome of allogeneic stem cell transplantation.
Wikell H; Ponandai-Srinivasan S; Mattsson J; Gertow J; Uhlin M
Transpl Infect Dis; 2014 Apr; 16(2):203-12. PubMed ID: 24456214
[TBL] [Abstract][Full Text] [Related]
16. Impact of CMV and EBV on Immune Recovery After Allogeneic Hematopoietic Cell Transplantation in Children.
Pukownik E; Kubicka M; Kurylo-Rafinska B; Debski R; Galazka P; Czyzewski K; Krenska A; Bartoszewicz N; Demidowicz E; Marjańska A; Dziedzic M; Pogorzala M; Wysocki M; Styczynski J
Anticancer Res; 2018 Oct; 38(10):6009-6013. PubMed ID: 30275233
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific T-lymphocyte function after cord blood transplantation.
Cohen G; Carter SL; Weinberg KI; Masinsin B; Guinan E; Kurtzberg J; Wagner JE; Kernan NA; Parkman R
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1335-42. PubMed ID: 17162216
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.
Lilleri D; Gerna G; Zelini P; Chiesa A; Rognoni V; Mastronuzzi A; Giorgiani G; Zecca M; Locatelli F
PLoS One; 2012; 7(7):e41648. PubMed ID: 22848556
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients.
Abate D; Cesaro S; Cofano S; Fiscon M; Saldan A; Varotto S; Mengoli C; Pillon M; Calore E; Biasolo MA; Cusinato R; Barzon L; Messina C; Carli M; Palù G
Transplantation; 2012 Mar; 93(5):536-42. PubMed ID: 22314338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
